Buffett, Sokol, Caesar’s wife must be above suspicion

I was quoted in FT about David Sokol, CEO of a Berkshire Hathaway subsidiary, buying shares in Lubrizol a few months before Buffett’s Berkshire Hathaway bought Lubrizol at a significant premium, which made Sokol 3 million dollars on his $10 million purchase. “Some investors expressed concerns about Mr Sokol’s actions. ‘Any time you buy stock…

I was quoted in FT about David Sokol, CEO of a Berkshire Hathaway subsidiary, buying shares in Lubrizol a few months before Buffett’s Berkshire Hathaway bought Lubrizol at a significant premium, which made Sokol 3 million dollars on his $10 million purchase.

“Some investors expressed concerns about Mr Sokol’s actions. ‘Any time you buy stock in a company which your employer then buys [it] just does not smell right,’ said Vitaliy Katsenelson, chief investment officer of Investment Management Associates.”

This quote slightly misstates my view, as the issue here is more complex.  Sokol was the CEO of MidAmerica and NetJets (subsidiaries of Berkshire); it is not his job to look for companies for Berkshire to buy – Buffett and Munger are in charge of Berkshire’s capital allocation decisions.  Sokol bought Lubrizol for his own account because he liked the business and thought it was attractively priced.  If he had never mentioned Lubrizol to Buffett, there would be no controversy today.  But he did, while disclosing that he owned the stock.  Buffett expressed little interest in Lubrizol.

Where this situation gets tricky is when Sokol starts communicating with Lubrizol’s CEO.  Lubrizol’s CEO (and the board) perceive him as the agent of Berkshire – even though Buffett at the time still had little interest in the company, because he was spooked, quite deservedly, by Lubrizol’s very high profit margins.  At dinner with Sokol, Lubrizol’s CEO discussed internal forecasts for 2015, which at the time must have been material nonpublic information, information that would not be shared with David Sokol – the private citizen, but was shared with David Sokol – the left-hand man (Munger being the right-hand man) of Buffett, who might have wanted to buy Lubrizol.  Only after this meeting was Buffett convinced to buy Lubrizol.

The magnifying glass of the media is now zooming in on Sokol, but the focus should be directed at Buffett as well.  Unfortunately, reputation is often destroyed by appearances.  We know Buffett cares deeply about his reputation.  To remove the appearance of impropriety, he could have ordered Sokol to sell his shares of Lubrizol in the public market, or to Berkshire.  Sokol would have obliged.

When you act on the behalf of someone else (be it a portfolio manager running someone else’s money, or an executive of a public firm) appearances are as important as the legality of one’s actions. You are like Caesar’s wife; you must be above suspicion.  You never want the true intent of your actions to be second-guessed, but unfortunately that is exactly what happened in this case.

Vitaliy N. Katsenelson, CFA, is Chief Investment Officer at Investment Management Associates in Denver, Colo.  He is the author of The Little Book of Sideways Markets (Wiley, December 2010).  To receive Vitaliy’s future articles by email, click here or read his articles here. .

Copyright Vitaliy N. Katsenelson 2010.  This article may  be republished only in its entirety and without modifications.

Please read the following important disclosure here.

Related Articles

Why I No Longer Mind Losing an Argument

Why I No Longer Mind Losing an Argument

Reflecting on my experience with Dale Carnegie's book, I share how it transformed my approach to criticism and debate, and why I no longer mind losing an argument.

How do I get any research done since I travel a lot?

I get asked at times: How do I get any research done since I travel a lot? To answer this question, I need to explain how we do research.
The Growing Pains of Maturity

The Growing Pains of Maturity

Many times, we bought because they were in their “junior year”; this is what made them undervalued. Our research led us to the conclusion that their difficulties were transitory and that as they matured the market would revalue them.
What is the Value of Apple? How do we evaluate risk?

What is the Value of Apple? How do we evaluate risk?

Today I will share the Q&A section of the letter. Every time I am almost finished with the client letter, I ask clients to send me any questions they have about their portfolio or other topics. I answer these questions in the Q&A section.

Leave a Comment